Dr. Chang is the Founder and Chief Scientific Officer of Integrity Bio, a 17-year-old company, based in Thousand Oaks, California, focused on formulation and cGMP fill/finish of injectable biologics. He recently founded the Vaccine Stabilization Institute, a company focused on formulating stabile viruses and viral vectors for vaccine and gene therapy applications.
Dr. Chang has over 30 years of experience in biopharmaceutical drug product development for companies including Amgen, Synergen, Cetus and SK&B. While at Integrity Bio, Dr. Chang has worked with hundreds of companies ranging from Global Fortune 500 companies to virtual biotechs. He has worked on a wide variety of therapeutic modalities totaling well over five hundred products. He holds a Ph.D. from the University of Massachusetts.